VC  Bridge Builders Collaborative

     Office Locations:

Minneapolis, MN



  • Early



  • Education & Training
  • Information Technology
  • Life Sciences & Healthcare
  • Media & Digital Media
  • Software & Internet



    Bridge Builders Collaborative is a firm that invests in social entrepreneurs who have scalable business models for applications, practices, products and tools that build bridges for mind-training and its impact on lives. Bridge Builders will take collaboration efforts between scientists, media, entrepreneurs, corporations, health care systems.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Austin Hearst Partner
    Charlie Hartwell Operating Partner
    Jeff Walker Partner
    Scott Beck Patrtner
    Scott Kriens Partner


    Recent Funding Events (trailing 12 months):







      PEAR Therapeutics



      Series C


    Portfolio companies include:

      Claritas Mindsciences
        web link

        web link

        web link

        web link

        web link

        web link

      Knowledge Factor
        web link

        web link

      PEAR Therapeutics
        web link


    Recent News: